These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24484993)

  • 1. Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction.
    Grigorescu V; Zhang Y; Kissin DM; Sauber-Schatz E; Sunderam M; Kirby RS; Diop H; McKane P; Jamieson DJ
    Fertil Steril; 2014 Apr; 101(4):1019-25. PubMed ID: 24484993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assisted reproductive technology treatment increases obstetric and neonatal risks over that of the underlying infertility diagnosis.
    Stern JE; Liu CL; Cui X; Cabral HJ; Farland LV; Coddington C; Diop H
    Fertil Steril; 2022 Jun; 117(6):1223-1234. PubMed ID: 35397876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment.
    Stern JE; Luke B; Tobias M; Gopal D; Hornstein MD; Diop H
    Fertil Steril; 2015 Jun; 103(6):1438-45. PubMed ID: 25813277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care.
    Tannus S; Tan J; Son WY; Dahan MH
    Arch Gynecol Obstet; 2018 Apr; 297(4):1037-1042. PubMed ID: 29289990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate.
    Kalra SK; Ratcliffe SJ; Dokras A
    Fertil Steril; 2013 Jul; 100(1):208-13. PubMed ID: 23557762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study.
    Roos N; Kieler H; Sahlin L; Ekman-Ordeberg G; Falconer H; Stephansson O
    BMJ; 2011 Oct; 343():d6309. PubMed ID: 21998337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcomes in very advanced maternal age pregnancies: the impact of assisted reproductive technology.
    Jackson S; Hong C; Wang ET; Alexander C; Gregory KD; Pisarska MD
    Fertil Steril; 2015 Jan; 103(1):76-80. PubMed ID: 25450294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment.
    Li Y; Ruan X; Wang H; Li X; Cai G; Du J; Wang L; Zhao Y; Mueck AO
    Fertil Steril; 2018 Apr; 109(4):720-727. PubMed ID: 29525688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometriosis and assisted reproductive technology: United States trends and outcomes 2000-2011.
    Kawwass JF; Crawford S; Session DR; Kissin DM; Jamieson DJ;
    Fertil Steril; 2015 Jun; 103(6):1537-43. PubMed ID: 25881877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second try: who returns for additional assisted reproductive technology treatment and the effect of a prior assisted reproductive technology birth.
    Luke B; Brown MB; Wantman E; Baker VL; Grow DR; Stern JE
    Fertil Steril; 2013 Dec; 100(6):1580-4. PubMed ID: 23987515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of maternal polycystic ovary syndrome or anovulatory infertility with obesity and diabetes in offspring: a population-based cohort study.
    Chen X; Koivuaho E; Piltonen TT; Gissler M; Lavebratt C
    Hum Reprod; 2021 Jul; 36(8):2345-2357. PubMed ID: 34046665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent Variables for Determining the Cumulative Live Birth Rates of Aged Patients with Polycystic Ovary Syndrome or Tubal Factor Infertility: A Retrospective Cohort Study.
    Guan Y; Kong P; Xiao Z; Zhang J; He J; Geng W; Yan J; Sun S; Mu M; Du X; Wang X
    Front Endocrinol (Lausanne); 2021; 12():728051. PubMed ID: 35111134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Assisted Reproductive Technology Outcomes of Hysteroscopic Tubal Microinserts Versus Laparoscopic Proximal Tubal Occlusion or Salpingectomy for Hydrosalpinges Treatment.
    Arora R; Shapiro H; Liu K; Arthur R; Cruickshank B; Sharma P; Glass K; Baratz A; Librach C; Greenblatt EM
    J Obstet Gynaecol Can; 2020 Jun; 42(6):779-786. PubMed ID: 32224160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
    Mostinckx L; Segers I; Belva F; Buyl R; Santos-Ribeiro S; Blockeel C; Smitz J; Anckaert E; Tournaye H; De Vos M
    Hum Reprod; 2019 Aug; 34(8):1595-1607. PubMed ID: 31347678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility treatment pathways and births for women with and without polycystic ovary syndrome-a retrospective population linked data study.
    Moss KM; Doust J; Copp T; Homer H; Mishra GD
    Fertil Steril; 2024 Feb; 121(2):314-322. PubMed ID: 38099868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational diabetes mellitus risk factors in women with polycystic ovary syndrome (PCOS).
    Ashrafi M; Sheikhan F; Arabipoor A; Hosseini R; Nourbakhsh F; Zolfaghari Z
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():195-9. PubMed ID: 25150960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates.
    Butts SF; Ratcliffe S; Dokras A; Seifer DB
    Fertil Steril; 2013 Feb; 99(2):382-8. PubMed ID: 23102859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of assisted reproductive technology utilization and outcomes between Caucasian and African American patients in an equal-access-to-care setting.
    Feinberg EC; Larsen FW; Catherino WH; Zhang J; Armstrong AY
    Fertil Steril; 2006 Apr; 85(4):888-94. PubMed ID: 16580370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased rates of complications in singleton pregnancies of women previously diagnosed with polycystic ovary syndrome predominantly in the hyperandrogenic phenotype.
    de Wilde MA; Lamain-de Ruiter M; Veltman-Verhulst SM; Kwee A; Laven JS; Lambalk CB; Eijkemans MJC; Franx A; Fauser BCJM; Koster MPH
    Fertil Steril; 2017 Aug; 108(2):333-340. PubMed ID: 28778282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.
    Chen X; Gissler M; Lavebratt C
    Hum Reprod; 2022 May; 37(6):1311-1323. PubMed ID: 35348682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.